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Bone resorption by osteoclasts is necessary to maintain bone homeostasis. Osteoclast differentiation from hematopoietic
progenitors and their activation depend on M-CSF and RANKL, but also requires co-stimulatory signals acting through
receptors associated with DAP12 and FcRc adaptors. Dap12 mutant mice (KD75) are osteopetrotic due to inactive osteoclasts
but, surprisingly, these mice are more sensitive than WT mice to bone loss following an ovariectomy. Because estrogen
withdrawal is known to disturb bone mass, at least in part, through lymphocyte interaction, we looked at the role of mature
lymphocytes on osteoclastogenesis and bone mass in the absence of functional DAP12. Lymphocytes were found to stimulate
an early osteoclast differentiation response from Dap12-deficient progenitors in vitro. In vivo, Rag1-/- mice lacking mature
lymphocytes did not exhibit any bone phenotype, but lost their bone mass after ovariectomy like KD75 mice. KD75;Rag1-/-
double mutant female mice exhibited a more severe osteopetrosis than Dap12-deficient animals but lost their bone mass after
ovariectomy, like single mutants. These results suggest that both DAP12 and mature lymphocytes act synergistically to
maintain bone mass under physiological conditions, while playing similar but not synergistic co-stimulatory roles in protecting
bone loss after gonadal failure. Thus, our data support a role for lymphocytes during osteoclast differentiation and suggest
that they may function as accessory cells when regular osteoclast function is compromised.
Citation: Anginot A, Dacquin R, Mazzorana M, Jurdic P (2007) Lymphocytes and the Dap12 Adaptor Are Key Regulators of Osteoclast Activation
Associated with Gonadal Failure. PLoS ONE 2(7): e585. doi:10.1371/journal.pone.0000585
INTRODUCTION
Bone remodeling and homeostasis result from the balanced
activity of two cell types, osteoclasts for bone resorption and
osteoblasts for bone formation. In humans, as well as in rodents,
bone goes through different phases of development. During the
growth phase, bone modeling takes place with a rate of formation
higher than that of degradation. Once puberty occurs, the bone
mass reaches a peak and subsequently remains constant through
a balanced formation and degradation process. Finally, during
aging, following gonadal failure and steroid hormone arrest, bone
degradation takes over from bone formation leading to osteopo-
rosis [1]. This aging process can be mimicked in animal models
such as mice, by gonadectomy, leading to an inhibition of steroid
hormone production and decreased bone mass.
In women, the major etiology of osteoporosis is estrogen
withdrawal after menopause. Many different studies have been
carried out in order to understand the mechanisms of estrogen
activity on bone mass, and to generate new therapies to prevent or
cure the disease. Despite this work, exactly how estrogens act on
bone cells still remains unclear. Most of the estrogen activity on
bone cannot be explained by a direct effect on bone cells [2].
Several lines of evidence indicate that disruption of the hormonal
status through variations in estrogen levels acts on the hemato-
poietic compartment and especially on B and T lymphocyte
precursors. An elevated estrogen level decreases B lymphopoiesis,
whereas a decrease in estrogen levels, following ovariectomy,
induces an accumulation of pre-B cells in bone marrow [3–5].
Moreover, in the last few years, many reports have emphasized the
role played by T lymphocytes through cytokine release, in the
control of bone mass under normal physiological conditions or
after gonadal failure [6]. T cells have been shown to be one of the
key activators of bone resorption via TNFa secretion, leading to
osteoporosis in the absence of estrogens [7,8]. However these data
remain controversial as Lee et al. (2006) have recently suggested
that T lymphocytes are not implicated in this process [9]. It is
currently difficult to have a clear opinion on the precise role of
lymphocytes in bone homeostasis, since lymphocytes secrete
RANKL, TNFa, IL-1, IL-6, OPG or IFNc, which have all been
shown to have either stimulatory or inhibitory effects on
osteoclastogenesis [10].
Mature multinucleated osteoclasts are formed by the fusion of
hematopoietic precursors of the myeloid/monocytic lineage.
Although, signals driven by Receptor Activator of NF-kB Ligand
(RANKL) and Macrophage-Colony-Stimulating Factor (M-CSF)
are clearly essential for osteoclastogenesis, regulation by other
receptor-mediated signals is less well defined. In addition, recent
data have implicated co-stimulatory signals through DAP12 and
FcRc molecular adaptors, which function in concert with many
receptors such as TREM2 and OSCAR, respectively [11]. DAP12
(also called KARAP or TYROBP) is a small transmembrane
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domain mediating all of its known effector functions. In humans,
TREM2 or DAP12 deficiencies are responsible for Nasu-Hakola
disease, a rare human disease, characterized at the bone level, by
osteoporotic lesions at the extremities of long bones [12,13]. In
contrast, Dap12 complete deletion or Dap12 loss of function
(KD75) in mice leads to osteopetrosis due to the presence in bones
of numerous but inactive multinucleated osteoclasts [14–17].
Interestingly, in humans and mice, the bone phenotype appears
just after puberty [18,19] (our unpublished data). Unexpectedly,
osteoclast differentiation and function of Nasu-Hakola patient-
derived mononuclear myeloid precursors is impaired in vitro,
similar to the severe block of osteoclast differentiation observed
when bone or spleen myeloid precursors from Dap12-deficient
mice are cultured in the presence of M-CSF and RANKL.
However, co-cultures of Dap12-deficient hematopoietic precur-
sors, together with M-CSF, RANKL and stromal cells or osteo-
blasts, can restore a weak osteoclastogenesis [14,16]. In vivo, murine
osteoclasts differentiate but function poorly whereas, in vitro, there
is an early block of osteoclastogenesis as no multinucleated
osteoclasts can be obtained. Differences between osteoclastogen-
esis in vivo and in vitro in humans and in mice, as well as co-culture
experiments, suggest that other co-stimulatory signals are present
in Dap12-deficient mice to allow osteoclast differentiation. Indeed,
Koga et al. (2004) have demonstrated that FcRc, the other ITAM
bearing adaptor protein expressed by osteoclasts, is critical for
osteoclast differentiation. Although single FcRc-/- mice do not
present any bone phenotype, Dap12;FcRc double knock-out mice
exhibit a severe osteopetrosis compared to single Dap12-/- mice
[14]. Therefore, in the absence of a functional DAP12 protein,
FcRc mediates co-stimulatory signals that can restore a weak
osteoclast differentiation. The binding of still unknown ligands to
DAP12- and FcRc- associated receptors leads to the phosphory-
lation of their ITAM motif, which activates syk kinase and
phopholipase Cc, resulting in the amplification of NFATc1, an
osteoclast master gene [14,15,20,21].
Since Dap12 deficiency affects bone resorption after puberty
and estrogens regulate the lymphoid cell compartment, we
hypothesize that lymphocytes could act as a co-stimulatory signal
to stimulate osteoclastogenesis in Dap12 loss of function mice. In
this paper, we first show that gonadal failure is a permissive
condition that triggers osteoclast resorption in KD75 mice. We
then address the role played by mature lymphocytes in normal
osteoclastogenesis and in bone physiology, analyzing Rag1-/- mice
lacking mature B and T lymphocytes, concomitantly with KD75
and double mutant Rag1-/-;KD75 mice. We show that mature
lymphocytes play a similar role to DAP12 in protecting against
bone degradation after ovariectomy in female adult mice. Our
data support a role for lymphocytes during osteoclastogenesis and
suggest that they may function as accessory cells under certain
conditions when regular osteoclast function is compromised.
RESULTS
Ovariectomy activates bone resorption in
Dap12-deficient mice
Since bone mass in Dap12-deficient mice increases due to the
inability of osteoclasts to resorb bone after puberty, we wanted to
check whether estrogen withdrawal after ovariectomy could reacti-
vate bone resorption and thus restore the bone mass phenotype.
For this purpose, 8-week-old KD75 and WT female mice were
ovariectomized and sacrificed 4 weeks later and their long bones
analyzed by histomorphometry (Figure 1A). Ovarian ablation was
complete since uteral weight was significantly lower in ovariecto-
mized compared to sham-operated mice (Figure 1B). Bone
histomorphometrical analysis showed that the control mice lost
30% of bone mass one month after ovariectomy, but KD75 mice
lost 45% of their bone mass under the same conditions (Figures 1A
and C). This showed that bone resorption, which is impaired in
KD75 adult mice, can be restored after ovariectomy. Because
ovariectomy is known to disturb lymphocyte population homeo-
stasis in the bone marrow we also analyzed the hematopoietic cell
distribution in the bone marrow and spleen of KD75 mice after
ovariectomy. As shown on Figure 1D, only the B220
+ B lym-
phocyte number doubled in the bone marrow after ovariectomy in
both WT and KD75 mice. The numbers of CD11b
+ monocytes,
and Gr1
+ granulocytes were not modified. In contrast, in spleen,
the numbers of B220
+ B lymphocytes, CD11b
+ monocytes,
CD11c
+ dendritic cells and Gr1
+ granulocytes were similar in
both KD75 and WT mice and were not modified by ovariectomy
(Figure 1E). It should be noted that CD11c dendritic cells in bone
marrow, as well as CD3
+ T lymphocytes in spleen had increased in
KD75 mice but not in response to ovariectomy. This increase in B
cell lymphocytes in the bone marrow of ovariectomized female
adult mice is in agreement with published data for wild type
ovariectomized mice [2,22]. This prompted us to analyze further
the role played by mature lymphocytes on Dap12-deficient
osteoclast progenitors.
Mature lymphocytes enhance osteoclast
differentiation of Dap12-deficient progenitors
Osteoclasts are present in Dap12-deficient mouse bones but are
poorly functional, whereas in vitro, they cannot be differentiated in
the presence of MCSF and RANKL, the two osteoclastogenic
cytokines. In order to analyze the role of lymphocytes in osteoclast
differentiation, we performed in vitro osteoclast differentiation from
spleen cells from Dap12 loss of function KD75 mice versus WT
littermates. Leukocytes, in the presence or absence of lymphocytes,
were plated in the presence of MCSF and RANKL. In WT mouse
cells, osteoclast differentiation occurred independently of the pres-
ence of lymphocytes (Figures 2A left panels and 2B). As expected,
after 7 days in culture, no osteoclasts differentiated from KD75
mouse leukocytes in the absence of lymphocytes. However, when
lymphocytes were present in large amounts, we noticed a signif-
icant increase in TRAP activity, since 20% of cells in culture were
TRAP+. Among these, multinucleated TRAP+ osteoclasts were
identified, representing a third of the total number of multinucle-
ated cells formed with WT precursors but containing, on average,
7 nuclei versus 20 in controls (Figures 2A and 2B). This lym-
phocyte mediated osteoclastogenic effect was not due to RANKL,
since addition of soluble RANKL to KD75 mouse leukocytes in the
absence of lymphocytes did not enhance osteoclast differentiation
(data not shown). So, in addition to M-CSF and RANKL, and
independently of RANKL concentration, lymphocytes partially
restore osteoclast differentiation from Dap12-deficient hematopoi-
etic precursor cells but have no stimulatory role on WT progenitors.
Mature lymphocytes do not stimulate bone
resorption activity of Dap12-deficient osteoclasts
Small multinucleated osteoclasts can be differentiated in vitro from
KD75 mouse splenocytes and TRAP activity is increased in the
presence of lymphocytes. We then checked whether, in addition to
osteoclastogenesis, lymphocytes also stimulate bone resorbing
activity of the formed osteoclasts. We evaluated several markers
typical of mature functional osteoclasts and compared these
activities with those of osteoclasts present in the bones of KD75
mice. We first analyzed by RT-PCR the expression of an early
Bone Mass Negative Regulators
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marker (calcitonin receptor, CTR). RNA was extracted from WT
and KD75 bones without bone marrow (‘‘in vivo’’) and from WT or
KD75 mouse spleen cell cultures, enriched or not with lym-
phocytes (‘‘in vitro’’). Both Cathepsin K and CTR were expressed
at similar levels in bones from WT or KD75 mice in vivo
(Figure 3A). During in vitro osteoclast differentiation, cathepsin K
was expressed at low levels and CTR was not detected in KD75
cells compared to WT cells. However, in lymphocyte enriched
cultures, cathepsin K and CTR were expressed by KD75 cells, as
well as by WT cells (Figure 3A). From these results we can
conclude that lymphocytes trigger the expression of differentiation
markers of KD75 osteoclast precursors. Because the main function
of osteoclasts is to resorb bone matrix, we then decided to examine
whether or not such differentiated osteoclasts would be able to
resorb apatite mineralized matrix like in vivo KD75 osteoclasts. For
this purpose, we analyzed both their ability to form an actin
containing sealing zone on calcium apatite and to resorb it.
Functional tests for osteoclast activity were carried out on ACC
(Apatite Collagen Complex) matrix. Osteoclasts differentiated
from WT mouse cells formed a typical sealing zone on the ACC
matrices (Figure 3B) and resorbed it, as resorption pits could be
observed in the vicinity of osteoclasts (Figure 3C, white arrow). In
contrast, osteoclasts differentiated from KD75 mouse spleen cells,
enriched in lymphocytes and spread on ACC matrix did not form
anysealingzonebutonlyactin-containinglamellipodia(Figure3D).
These were not functional since they did not resorb the miner-
alized matrix (Figure 3E). This absence of resorption was also
verified on dentine slices (not shown). So, in the presence of
M-CSF and RANKL as well as lymphocytes, spleen cells from
KD75 mice can differentiate into multinucleated osteoclasts but
these are not functional similarly to what is observed in vivo
inKD75 mice. Thus, by adding lymphocytes to in vitro cultures we
can reproduce the in vivo osteoclast phenotype. During osteoclas-
togenesis, mature lymphocytes may act as accessory cells in the
absence of a functional DAP12 protein.
Figure 1. Ovariectomy of KD75 mice triggers bone mass reduction. Ovariectomy (ovx) was performed on 8-week-old WT and KD75 mice. 4 weeks
later, ovariectomized and sham operated animals were sacrificed. (A) Histomorphometric analysis was performed on long bones after Von Kossa/Von
Gieson staining. (B) Efficiency of ovariectomy was assessed by weighing uteri. (C) Bone mass was quantified. Results of the quantification show that
WT mice lost 30% of bone mass after ovariectomy, whereas KD75 mice lost around 45%. (D and E) Hematopoietic populations from bone marrow (D)
or spleen (E) were characterized by flow cytometry using the B220 antibody for B lymphocytes; CD11b for monocytes; CD11c for dendritic cells; Gr1
for granulocytes and CD3 for T lymphocytes. (* p,0.01, ** p,0.001, *** p,0.0001)
doi:10.1371/journal.pone.0000585.g001
Bone Mass Negative Regulators
PLoS ONE | www.plosone.org 3 July 2007 | Issue 7 | e585Figure 2. Lymphocytes enhance osteoclastogenesis from KD75 but not from WT mouse spleen cells. (A) WT and KD75 mice spleen cells were
isolated using different lymphocyte separation media to collect osteoclast precursors without (upper panels) or with (lower panels) lymphocytes.
Osteoclast differentiation was carried out in the presence of M-CSF and RANKL. Seven days later, cell cultures were fixed and stained for TRAP activity.
Lymphocytes increased the formation of TRAP positive osteoclasts from KD75 spleen cells (KD75+Ly). Pictures of representative fields from several
experiments. (B) Quantification under the different culture conditions, of the number of TRAP+ cells per dish; TRAP+ osteoclasts with more than 3
nuclei; average number of nuclei per multinucleated osteoclast. These figures are representative of three different experiments. (* p,0.01, **
p,0.001, *** or {{{ p,0.0001)
doi:10.1371/journal.pone.0000585.g002
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mass only in the absence of a functional DAP12
protein
As lymphocytes compensate for Dap12 deficiency for in vitro
osteoclastogenesis, we decided to evaluate the importance of
lymphocytes in the control of bone mass. We chose the Rag1-/-
mouse model deficient in both mature T and B lymphocytes [23].
We generated Rag1-/- or KD75 as well as Rag1-/-;KD75 (DKO)
double mutant mice with identical genetic backgrounds. The bone
parameters (BV/TV) of 12-week-old female mice were analyzed
first with a micro scanner (Data S1) and also, for confirmation, by
histomorphometry on calcified bones (Figure 4A and B). We first
observed that Rag1-/- mice did not present any particular bone
phenotype in comparison to WT animals of a similar genotype.
This genetic approach allowed us to confirm once again that
KD75 mice had an increased bone mass (21%) compared with
WT or Rag1-/- mice. More importantly, we observed that DKO
mice had an even higher increased bone mass to compare with
KD75 (30%) and control or Rag1-/- mice (60%) (Figure 4A,
Table 1). In comparison with other mice, trabeculae thickness was
unchanged in the DKO animals. In addition, the number of
trabaculae had increased, whereas the space between them was
reduced. This phenotype is mostly due to impairment of osteoclast
function, since the number of osteoclasts counted on bone surfaces
was similar for all four backgrounds (Figure 4B), while collagen
type I degradation products present in the urine of 12-week-old
DKO female mice had decreased by 17% compared with WT
females (Figure 4C). This was further confirmed in 6-month-old
male mice in which collagen type I degradation products had
decreased in both KD75 and DKO mice, compared with WT and
Rag1-/- mice (Figure 4D). These data demonstrate that the
absence of mature B and T lymphocytes does not affect bone mass
in mice with a normal genetic background but acts synergistically
with a Dap12 deficiency to increase bone mass by inhibiting
osteoclast activity (Table 1).
Mature lymphocytes are not implicated in bone loss
after ovariectomy
As DAP12 activity protects against bone loss after ovariectomy
and lymphocytes seem to play a similar accessory role, we wanted
to know whether Dap12 deletion would act independently or
synergistically with mature lymphocyte depletion. Eight-week-old
Rag1-/- and DKO female mice were ovariectomized or sham
operated, and one month later were sacrificed for bone histomor-
phometry analysis (Figure 5A). The uteri of sacrificed sham
operated and ovariectomized animals were weighed to ensure that
the ovariectomy had been successful (Figure 5B). BV/TV
evaluated by microscanner imaging (not shown) and histomor-
phometry analysis showed that Rag1-/- mice had lost more than
50% of their bone mass (Figure 5C) compared with the 30% lost
by WT female mice (Figure 1C), suggesting that mature
lymphocytes play an important role in protecting against bone
loss after gonadectomy (Table 1). Double mutant mice deficient in
both Dap12 and mature lymphocytes also lost 50% of their bone
mass (Figure 5C), compared with 45% bone loss after ovariectomy
of KD75 mice (Figure 1C). In summary, it is possible to compare
levels of bone loss after ovariectomy in the absence of mature
lymphocytes and in the presence or absence of functional DAP12
protein (Data S2). Strikingly, although WT female mice lost 30%
of bone mass after ovariectomy, the bone loss was 45 to 50% for
mice lacking lymphocytes in the presence or absence of a func-
tional Dap12 gene. In addition, the protective effects of DAP12
and lymphocytes on bone mass loss after ovariectomy were not
cumulative (Table 1).
DISCUSSION
DAP12 is a molecular adaptor for transmembrane receptors of
unknown ligands, which signals through an ITAM domain. It is
required for normal bone homeostasis because mice with impaired
DAP12 function, either by targeted inactivation of the ITAM
domain or through its complete deletion, develop osteopetrosis
after puberty due to the inability of osteoclasts to resorb bone. In
Figure 3. Lymphocytes trigger osteoclast marker expression but not
bone resorption from KD75 hematopoietic precursors. Expression of
cathepsin K (Cath K) and calcitonin (CTR) receptors by RT-PCR. RNAs
were extracted from WT and KD75 mouse spleen cell cultures (in vitro)
maintained for 7 days with MCSF and RANKL, with or without (+Ly)
lymphocytes. As a control, RNAs from WT and KD75 mouse bones (in
vivo) were also used. Under in vivo conditions, both Cath K and CTR
were expressed in WT and KD75 mouse bones, as well as in in vitro
cultures from corresponding spleen cell cultures. However, in the
absence of lymphocytes in in vitro cultures, Cath K is weakly expressed
and CTR is absent from KD75 mouse cell cultures. (B–E) Functional
resorption tests on mineralized ACC matrix. Osteoclasts were differen-
tiated in Petri dishes from WT and KD75 mouse spleen cells in the
presence of lymphocytes, and then removed before being plated on
ACC matrix. After 24h, cell cultures were fixed and stained with
phalloidin (B, D) and their resorption ability was evaluated by the
formation of pits (C, D). WT osteoclasts on ACC matrix exhibited a typical
actin-containing sealing zone associated with resorption (B, C white
arrow). In contrast, actin from KD75 derived osteoclasts did not form
a sealing zone but was mostly arranged in lamellipodia (D) and these
did not resorb apatite (E).
doi:10.1371/journal.pone.0000585.g003
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PLoS ONE | www.plosone.org 5 July 2007 | Issue 7 | e585Figure 4. Absence of mature lymphocytes in vivo enhances the osteopetrosis phenotype in KD75 mice through inhibition of osteoclast
function. KD75 mice were crossbred with Rag1-/- mice devoid of mature lymphocytes. The bone phenotype of KD75;Rag1-/- mice (called DKO), as
well as control littermates (DWT, Rag1-/- and KD75 mice), was quantified by histomorphometric analysis. (A) Bone mass was assessed after Von Kossa/
Von Gieson staining; trabeculae numbers, thickness and space between trabeculae were quantified using specific softwares. KD75 mice have a mild
but significant osteopetrosis compared with DWT mice. Rag1-/- mice did not exhibit any bone phenotype whereas osteopetrosis in KD75 mice
increased in the absence of lymphocytes (DKO mice) and was statistically significant, compared to DWT or KD75 mice. (B) TRAP
+ osteoclast numbers
per bone surface unit were assessed directly on bone slices. No statistical differences were observed between animals of the four different genotypes.
(D and E) Deoxypyridinoline cross-link degradation products were measured in evening urines and expressed as a ratio with creatinine in 3-month-
old females (C) and 6-month-old males (D). (*or { p,0.01, ** p,0.001, *** p,0.0001)
doi:10.1371/journal.pone.0000585.g004
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expanded on these previous data by showing unexpectedly that
bone resorption in mutant adult female mice is restored after
ovariectomy. KD75 adult female mice were much more sensitive
to ovariectomy than WT littermates. Looking for potential
cofactors that could act together with DAP12, to maintain bone
homeostasis during adult life, we turned our interest toward
lymphocytes. Adult Rag1-/- mice, which do not produce any
mature B and T lymphocytes, do not present any bone phenotype
but suffer a massive decrease in bone mass after ovariectomy.
However, double mutant mice with an inactivated DAP12 protein
in the absence of mature lymphocytes had increased osteopetrosis
compared with KD75 mice and their bone mass was decreased to
the same extent as KD75 animals after ovariectomy (Table 1).
Increasing evidence suggests that immune and skeletal systems
share a number of regulatory molecules, but the role played by
lymphocytes in bone homeostasis is still controversial [6,24]. It has
been proposed that T lymphocytes are important players in
postmenopausal osteoporosis [25] but opposing data have also
been published [9]. T lymphocytes could act directly or indirectly
on bone cells and mostly on osteoclasts through the secretion of
various cytokines. However, even this is difficult to reconcile since
T lymphocytes have been reported to secrete cytokines with
osteoclastogenic activities such as RANKL, TNFa, IL1, IL6 or
antiosteoclastogenic factors such as OPG. The effects of T cells on
osteoclastogenesis should depend on the balance between the
positive and negative factors that they express. For example, T
cell-produced IFNc which has been reported to inhibit osteoclas-
togenesis directly but to stimulate it indirectly through antigen-
driven T cell activation [26,27]. On the other hand, the role
played by B lymphocytes is mostly recognized through the
observation that B lymphopoiesis is stimulated during estrogen
deficiency [22,28]. We reconfirmed this although only in the bone
marrow of ovariectomized mice and not in spleen. It is therefore
extremely difficult to reconcile all these contradictory data, which
could also depend on the genetic background of animals studied. It
Table 1. Summary of bone mass phenotype in normal or ovariectomized 3-month-old female mice according to genotype
..................................................................................................................................................
Mice genotype DWT KD75 Rag1 -/- DKO
Bone mass Normal Mild osteopetrosis Normal Severe osteopetrosis
Bone mass after ovariectomy Reduced (30%) Highly reduced (50%) Highly reduced (50%) Highly reduced (50%)
doi:10.1371/journal.pone.0000585.t001
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Figure 5. Mature lymphocytes and DAP12 protect against gonadal failure induced bone loss. Ovariectomies were performed on 8-week-old
Rag1-/- and DKO mice. Four weeks later, both ovariectomized and sham operated animals were sacrificed. (A) Bone mass was assessed by
histomorphometric analysis after Von Kossa/Von Gieson staining. (B) The efficiency of ovariectomy was evaluated by weighing the uteri. (C) Results of
the quantification show that Rag1-/- mice, as well as KD75;Rag1-/- mice, lost more than 50% of their bone mass after ovariectomy. (*** or {{{
p,0.0001)
doi:10.1371/journal.pone.0000585.g005
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involved in osteoclastogenesis could play different, or even
opposite roles in specific anatomical bone microenvironments as
Wu et al. have shown for ITAM-bearing coadaptors [Wu et al.,
2007, PLOSone]. In this work we show that in the specific context
of Rag1-deficient mice, mature B and T lymphocytes do not play
any role in normal adult bone homeostasis but overall bone mass is
drastically reduced after ovariectomy. We cannot rule out the
possibility that T and B lymphocytes play opposite roles, which are
then nullified in the absence of the two populations. To decipher
the role played by lymphocytes in bone homeostasis the specific
role of lymphocyte subpopulations will have to be addressed.
Indeed, a recent report by Sato et al. has shown the specific
importance of the T helper 17 (Th17) subpopulation through
secretion of IL17 in bone destruction in rheumatoid arthritis [29].
The protective effect of DAP12 on ovariectomy-induced bone
loss has been emphasized since we show here that bone resorption
activity can be restored after ovariectomy of Dap12 loss of
function mutant mice. Similar results have been obtained with
female mice in which Dap12 has been completely deleted [Wu et
al., 2007, PLOSone]. In the physiopathological context of gonadal
failure, DAP12 impairment and lymphocyte depletion do not act
synergistically since bone mass reduction after ovariectomy is the
same when either one or both of these factors are disturbed (Data
S2). However, B and T lymphocytes can partially compensate for
the lack of DAP12 in vitro and in vivo. Indeed, from our in vitro
studies we have shown that lymphocytes enhance Dap12-deficient
osteoclast precursor differentiation but do not activate their bone
resorbing activity like osteoblasts or stromal cells [15,16,19]. This
supports the observation that in vivo, the inhibition of osteoclast
activity in KD75 mice is more drastic in the absence of
lymphocytes, leading to a more severe osteopetrosis, reinforcing
the hypothesis that lymphocytes are somehow implicated in the
control of bone mass reduction in relation to Dap12 deficiency.
From our results we can propose that lymphocytes play a similar
role to the FcRc co-stimulatory pathway on osteoclastogenesis and
bone mass homeostasis [14,15,30]. Indeed, the absence of mature
lymphocytes in vivo mimics FcRc deficiency as far as bone mass
homeostasis is concerned, according to data reported by Wu et al.
(accompanying article). It is then possible to conclude that Dap12
and mature lymphocytes play similar roles in protecting bone mass
in the specific context of gonadal failure.
MATERIALS AND METHODS
Mice
KD75 loss-of-function mice were derived from eight backcrosses
with C57BL/6 mice [31]. KD75 mice and Rag1-/- (C57Bl/10)
(Charles River Laboratories) mice were crossbred to obtain double
heterozygotes. All mice used came from the crossbreeding of the
double heterozygote mice. They were bred and kept under
pathogen free conditions with sterilized food, water and bedding in
the Plateau de Biologie Experimentale de la Souris (IFR128 Lyon
Biosciences, Lyon, France). To induce sex hormone deficiency, 8-
week-old female mice underwent transabdominal ovariectomies
(OVX), whereas the controls consisted of sham-operated mice
(SHAM). Surgery was performed under general anesthesia using
a Xylasine (12 mg/kg, Sigma)/Ketamine hydrochloride (0.1 mg/
kg, Centravet) mixture, following procedures in agreement with
the ethical rules set by the IFR 128 animal facility committee.
Cell cultures
Leukocytes were isolated from 8-week-old mouse spleens. Spleens
were dissociated in complete medium (aMEM (Life technologies),
10% serum (Biowest), 2 mM L-Glutamine, 100U/mL Penicillin,
100 mg/ml streptomycin (Invitrogen)), then filtered through a
100 mm cell strainer (Falcon). Two lymphocyte separation media
with different densities were used to isolate leukocytes: Eurobio
(density 1.077 g/cm
3) and Lympholyte-M (density 1.0875 g/cm
3;
Cederlane) (The high density medium allowed lymphocytes to be
excluded from nucleated spleen cells such as monocytes, NK cells
or dendritic cells. Leukocytes isolated from WT and KD75 mice,
plated at 2500 cells/mm
2, or from Rag1-/- and double mutant
mouse cells plated at 250 cells/mm
2 were cultured in complete
aMEM in the presence of M-CSF and RANKL. Osteoclast
differentiation was evaluated by Tartrate Resistant Acid Phospha-
tase staining, using the Leucocyte Acid Phosphatase kit (Sigma).
Recombinant murine M-CSF and human RANKL were pro-
duced in our laboratory using insect cells baculovirus system and
Pichia pastoris recombinant yeast cells, respectively [32].
Apatite Collagen Complex (ACC) coverslips to test osteoclast
resorption ability are composed of glass coverslips coated with type
I collagen and mineralized by calcium apatite crystals, which can
be resorbed by mature osteoclasts. They were prepared according
to a method described previously [33,34].
Immunofluorescence
Osteoclasts differentiated from spleen leucocytes in the presence of
M-CSF and RANKL, were detached with PBS EDTA (0.25 mM)
and plated on ACC slices overnight at 37uC. Cells were then fixed
in 4% paraformaldehyde (pH 7.2) for 15min at 4uC and rinsed
with PBS. They were then labeled with phalloidine-Alexa 546 and
observed with a confocal microscope (model LSM510; Carl Zeiss
MicroImaging, Inc.). Resorption pits were directly observed by
phase contrast microscopy.
Reverse Transcriptase and Polymerase Chain
Reaction
mRNA was extracted with RNAnow reagent (Biogentex) either
from in vitro cell cultures, or directly from bones devoid of marrow,
crushed in liquid nitrogen. Aliquots (1 mg) were reverse transcribed
using the MuLV-RT kit (Promega). Polymerase chain reactions
were performed with specific primers using the Taq polymerase kit
(Eurobio). Oligonucleotides were designed as follows:
-GAPDH 59-CAAAGTGGAGATTGTTGCCAT-39
39-CACCACCTTCTTGATGTCATC-59
-Cathepsin K 59-TTAATTTGGGAGAAAAACCT-39
39-AGCCGCCTCCACAGCCATAAT-59
-Calcitonin receptor 59-TGGTGGAGGTTGTGCCCAATGGA-
GA-39
39-CTCGTGGGTTTGCCTCATCTTGGTC-59
Bone Parameters and Histomorphometric Analysis
Bones were fixed in PBS plus 4% paraformaldehyde over night at
4uC and then stored in 70% ethanol. Femurs were scanned by
high resolution micro-CT (mCT-20, Scanco Medical, Bassersdorf,
Switzerland) with a cubic voxel size of 9 mm and the 3D structural
parameters calculated. For histomorphometric analysis, calcified
bones were fixed and embedded in methylmethacrylate according
to standard protocols [35]. Seven mm thick methyl methacrylate
sections were used for Von Gieson/Von Kossa staining as well as
for TRAP/hematoxylin stainings. Bone cellular and macroscopic
measurements were made using a microscope (model DMLB;
Leica), a 3CCD color video DXC-390 camera (Sony) and the
OsteoMeasure Analysis System (Osteometrics). Bone-related
degradation products from type 1 collagen, deoxypyridinoline
Bone Mass Negative Regulators
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the Pyrilinks-D immunoassay and creatine kit (Quidel corporation,
San Diego, CA), according to the manufacturer’s protocols.
Animal groups were composed of a minimum of 6 to 8 mice.
Statistical differences between groups were assessed using the
Students t test.
SUPPORTING INFORMATION
Data S1 The bone phenotype of DKO, Rag1-/- and K D 75
mice and control littermates DWT was imaged (A) and quantified
(B) by microscanner in order to confirm the histomorphometric
analysis (Figure 4). K D 75 mice exhibited mild but significant
osteopetrosis compared with DWT mice. Rag1-/- mice did not
exhibit any significant bone phenotype whereas the osteopetrosis
of K D 75 mice had increased in the absence of lymphocytes
(DKO mice). (* p,0.01, ** p,0.001)
Found at: doi:10.1371/journal.pone.0000585.s001 (2.43 MB TIF)
Data S2 Percentage of bone mass loss after ovariectomy in 3-
month-old female mice of identical genetic background.
Found at: doi:10.1371/journal.pone.0000585.s002 (0.22 MB TIF)
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